SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Fresh ESMO oncology updates are drawing attention, including early ovarian-cancer data for Lillys investigational Sofe-M combination; traders also debate the pullback and upcoming earnings, with bullish breakout hopes countered by concerns about fading momentum and resistance.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck and Modernas Phase 3 melanoma results for a personalized cancer vaccine added to Keytruda are the main focus, with the combination meeting recurrence-free and distant metastasis-free survival endpoints. Traders see the data as validation of Mercks oncology pipeline, while debating the vaccines broader potential, path to approval and commercial value against valuation concerns.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

SHIB is drawing attention for choppy, range-bound trading, with repeated chart commentary describing consolidation. Holders see the pullback as a chance to accumulate or set up a rebound, while skeptics point to weak utility and worry about further declines.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

KTOS is drawing attention for its steep selloff toward 52-week lows, despite reported contract wins, analyst upgrades, and past earnings beats. Traders debate whether the decline reflects an expensive valuation, insider selling, and concerns about turning demand and production growth into profitsor an overdone pullback in a defense and drone company with long-term growth prospects.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

Chinas rare-earth export restrictions and uncertain U.S.-China negotiations have renewed attention on MPs role in building a domestic mine-to-magnet supply chain. Traders remain divided: some see geopolitical and government support as a long-term tailwind, while others focus on the stocks prolonged decline and question near-term execution and demand.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Traders are focused on CVSs November 4 earnings report, with many positioning for a rebound after the stocks recent pullback and pointing to technical support. Others are wary of sellers and whether the shares can regain momentum ahead of the results.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is drawing attention amid broad-market concerns about elevated rates, inflation, energy costs and a possible AI-led correction, with traders debating whether recent weakness signals deeper risk or a buying opportunity. Some favor long-term index investing and dollar-cost averaging, while others expect further volatility and declines.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is drawing attention around its earnings setup, with traders citing stronger engagement tied to the viral game Steal an Egg and analyst optimism about bookings. Bullish momentum and call positioning compete with caution about earnings volatility and the stocks history of sharp post-report moves.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Attention centers on reports that the administration is weighing temporary access to certain compounded peptides, which traders view as a potential growth opportunity for Hims; no approval is confirmed. Optimism about peptides and a possible short squeeze contrasts with frustration over repeated reversals and resistance near $30.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellias FDA-accepted BLA for lonvo-z, granted Priority Review for hereditary angioedema, is the main catalyst, with traders focused on the March 2027 decision and the therapys Phase 3 results. Bulls see a potential path toward commercialization and validation of the gene-editing platform, while bears point to cash needs, commercialization risks and volatile trading.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

China SXT Pharmaceuticals, Inc. Announces Share Consolidation China SXT Pharmaceuticals, Inc. Announces Share ConsolidationPR NewswireTAIZHOU, China, Oct. 22, 2026 TAIZHOU, China, Oct. 22, 2026 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (the "Company"), today announced that it...

China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right

China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase RightPR NewswireTAIZHOU, China, Oct. 21, 2026 TAIZHOU, China, Oct. 21, 2026 /PRNewswire/ -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the...

China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering

China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct OfferingPR NewswireTAIZHOU, China, Oct. 8, 2026TAIZHOU, China, Oct. 8, 2026 /PRNewswire/ -- ChinaSXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the...

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 64.0% to $2.05 during Tuesday's after-market session. The market value of their outstanding shares is at $1.1 million.
Neogen (NASDAQ:NEOG)read more...

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 41.1% to $0.09 during Friday's after-market session. The market value of their outstanding shares is at $12.7 million.
iTonic Holdingsread more...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers

InMed Pharmaceuticals (NASDAQ:INM) stock moved upwards by 66.8% to $2.57 during Wednesday's pre-market session. The company's market cap stands at $8.2 million.
China SXT Pharmaceuticals (NASDAQ:SXTC)read more...

China SXT Pharmaceuticals Shares Surge Over 25% After Hours: Here's Why

China SXT Pharmaceuticals shares rose 25.6% after hours after announcing an ATM equity offering of up to $100 million via Univest Securities.read more...

Chinese Stocks To Keep An Eye On - April 15th

Charming Medical, Diageo, UP Fintech, Regencell Bioscience, RBB Bancorp, Hf Foods Group, and China SXT Pharmaceuticals are the seven Chinese stocks to watch today, according to MarketBeat's stock...

Promising Chinese Stocks To Follow Today - April 8th

Charming Medical, Diageo, UP Fintech, Regencell Bioscience, China SXT Pharmaceuticals, RBB Bancorp, and Hf Foods Group are the seven Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are publicly traded shares of companies that are incorporated in mainland...

Promising Chinese Stocks Worth Watching - March 30th

Charming Medical, Diageo, UP Fintech, Regencell Bioscience, RBB Bancorp, China SXT Pharmaceuticals, and BGM Group are the seven Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are equity securities issued by companies that are incorporated in or derive t...

China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). Its product categories include directly-oral, after-soaking-oral, fine, and regular TCMP. The firm distributes its product under the Suxuantang brand. The company was founded by Feng Zhou in 2005 and is headquartered in Taizhou, China.

China SXT Pharmaceuticals Inc - Ordinary Shares - Class A

This Nano-cap Pharma Stock Crashed 30% Today – What Triggered The Sell-off?

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>The action will reduce outstanding shares from about 143.7 million to 958,000.</li><li>The move is aimed at boosting the share price to regain compliance with Nasdaq’s $1 minimum bid price requirement.</li><li>SXTC shares have been under intense selling pressure since the turn of the year, declining more than 75%.</li></ul>Shares of China SXT Pharmaceuticals (SXTC) plunged nearly 30% on Friday after the company announced a 1-for-150 reverse share split, effective Feb. 3, 2026.<a href="https://stocktwits.com/symbol/SXTC">SXTC stock</a> will begin trading on a post-split basis the same day under the existing ticker symbol. The move is aimed at boosting the share price to regain compliance with Nasdaq’s $1 minimum bid price requirement. The stock is currently trading around $0.3.The move will consolidate every 150 existing Class A shares into one new share, reducing the outstanding shares from about 143.7 million to 958,000, with fractional shares rounded up.<h2 class="st-heading-2">Selling Pressure</h2>SXTC shares have been under immense selling pressure since the turn of the year, declining more than 75%. On January 9, the stock tanked 87% after the company signed a deal with a single investor to sell about 66.7 million Class A shares, or pre-funded warrants, at $0.15 each, for gross proceeds of around $10 million. The per-share offer was at an 88% discount.Recently, China SXT Pharmaceuticals launched an AI initiative to modernize the traditional Chinese medicine raw-material supply chain. The company said it would explore AI tools for cultivation monitoring, authenticity checks, quality grading, and demand forecasting to boost traceability and planning efficiency.The company’s last reported quarterly results were for the quarter ended September 2025, when its net loss widened to $6.3 million from about $0.8 million a year earlier.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the steep intra-day decline, retail sentiment on Stocktwits remained ‘extremely bullish’ over the past 24 hours, amid ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/SXTC_jpg_144e91e8f3.webp" alt="SXTC.jpg">Read also: <a href="https://stocktwits.com/news-articles/markets/equity/spot-gold-silver-plunges-precious-metals-selloff/cmySYVyR4SZ">Gold Falls Below $5,000, Spot Silver Plunges 20%</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

S&P 500 Index trades listlessly ahead of Nvidia earnings. 

China SXT Pharmaceuticals announced a 1-for-150 reverse share split, effective Feb. 3, 2026.

China SXT Pharmaceuticals Inc

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

SXTC News